Abstract
The purpose of this study is to compare between the efficacy of Bleomycin and Sodium tetra decyl sulphate as intralesional sclerotherapy for lymphangioma. Materials and methods- This prospective study was done between Jan 2018 to Jan 2020. Total of 30 patients with lymphatic malformations at head neck, axilla, chest wall and lower limb were included. Group I was given intralesional injection of bleomycin and Group II was injected with STS. All the cases were evaluated for a minimum period of one and a maximum of 2 years. Result Efficacy of bleomycin was found to be superior to STS, when used as intralesional sclerotherapic agent. Most of the vascular lesions of group I resolved after first dose giving excellent response in 60% as compared to 40% in STS group. Conclusion Intralesional bleomycin and sodium tetradecyl sulphate are safe and effective sclerosing agents in lymphangiomas of children, but bleomycin is more effective in reducing the size of the lesions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
